Phase 3 EPIDYS MRI data quantify givinostat’s potential to preserve functional muscle tissue and reduce fat infiltration in patients with…
Investigational n.c.a. 177Lu-edotreotide (ITM-11) demonstrated a significantly higher progression-free survival and objective response rate vs. everolimus Garching / Munich, July…
Highly Experienced US-Based Public Markets Leader Strengthens Team as Company Drives Late Stage Development of LEVI-04 for Osteoarthritis July 07,…
Vancouver, BC, July 06, 2026 (GLOBE NEWSWIRE) -- SalesCloser Technologies Ltd. (“SalesCloser” or the “Company”) (TSXV: SCAI) (FSE: MJ5), a…
July 06, 2026 16:10 ET | Source: SEALSQ Geneva, Switzerland, July 06, 2026 (GLOBE NEWSWIRE) -- Preliminary H1 2026 revenue…
July 06, 2026 16:05 ET | Source: Sprout Social, Inc CHICAGO, July 06, 2026 (GLOBE NEWSWIRE) -- Sprout Social, Inc.…
NETANYA, Israel, July 06, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), announced today following…
-- New Corporate Identity Reflects Strategic Transition into AI Energy Infrastructure Equipment & Services Sector Following Acquisition of NOMAD Transportable…
July 06, 2026 08:30 ET | Source: Neuronetics MALVERN, Pa., July 06, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM),…
WEST PALM BEACH, FL, July 06, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC: FOXOD/FOXO) (the “Company”) announces the following mid-year…